'Govt Allowing This to Happen': Supreme Court Questions on Overpricing of Medicines, Massive Gap in MRP and Cost to Retailers
The bench said regulators appear defunct and cited two petitions as it questioned why medicine prices vary so widely for retailers and consumers.
9 Articles
9 Articles
Why is entire system working to help pharma companies, asks SC
The Supreme Court has questioned the Centre regarding the significant disparity between the Maximum Retail Price (MRP) of medicines and their price to retailers, suggesting the entire system might be favouring manufacturers. The court also expressed concerns about the National Pharmaceutical Pricing Authority (NPPA)'s effectiveness, despite the Centre's argument that medicine prices in India are among the lowest globally. The bench has reserved …
'Why Is The Entire System Working To Help Manufacturers?’ SC Questions Medicine Pricing
<p>New Delhi, Oct 27 (PTI) Why is the entire system working to help pharmaceutical manufacturers, asked the Supreme Court on Tuesday while questioning the Centre over the massive difference between the MRP of medicines and the price to retailers.</p> <p>The Centre told the apex court that the government policy "is that the entire ecosystem is not to be controlled".</p> <p>"Why is the entire system working to help these people (manufacturers)," a…
'Govt allowing this to happen': Supreme Court questions on overpricing of medicines, massive gap in MRP and cost to retailers
The SC bench questioned why the system appeared to favour pharmaceutical manufacturers and asked whether such practices should be allowed to continue unchecked
The Supreme Court has asked tough questions to the Centre on the MRP, retail price and 30% trade margin of cancer drugs. The court said that citing the expenses of hospitals, it cannot be justified to charge patients 100 or 200 times the cost for the medicine.
The Supreme Court has strongly questioned the government's negligence in rectifying the huge gap between the maximum retail price (MRP) of medicines in India and the actual price paid by retailers. Hearing two petitions challenging the irregularities and discrepancies in drug pricing in India, a bench of Justices Vikram Nath and Sandeep Mehta asked, "Why is the entire system working in favour of pharmaceutical companies?" and reserved its order …
Coverage Details
Bias Distribution
- 80% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
